Extracorporeal membrane oxygenation (ECMO) in patients with tuberculosis: systematic review and meta-analysis of 43 cases.
Raja IdrisAnn-Sophie ZielbauerJulia KoepsellJan Andreas KlokaNils WetzsteinPublished in: BMC pulmonary medicine (2024)
ECMO therapy in TB patients appears to be a feasible therapeutic option, providing a bridge until antimycobacterial therapy takes effect. As the underlying cause is reversible, we advocate for the evaluation of ECMO usage in these patients with acute cardiac or respiratory failure.
Keyphrases
- extracorporeal membrane oxygenation
- respiratory failure
- acute respiratory distress syndrome
- end stage renal disease
- mechanical ventilation
- mycobacterium tuberculosis
- newly diagnosed
- ejection fraction
- chronic kidney disease
- left ventricular
- prognostic factors
- heart failure
- hiv aids
- stem cells
- patient reported outcomes
- hepatitis c virus
- patient reported
- replacement therapy
- atrial fibrillation
- bone marrow
- antiretroviral therapy